Recap: PAVmed Q1 Earnings

PAVmed (NASDAQ:PAVM) reported its Q1 earnings results on Tuesday, May 16, 2023 at 05:00 PM. Here’s what investors…

PAVmed (NASDAQ:PAVM) reported its Q1 earnings results on Tuesday, May 16, 2023 at 05:00 PM.

Here’s what investors need to know about the announcement.

Earnings

PAVmed beat estimated earnings by 52.38%, reporting an EPS of $-0.1 versus an estimate of $-0.21.

Revenue was up $257 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 6.68% drop in the share price the next day.

Here’s a look at PAVmed’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.25 -0.26 -0.23 -0.20
EPS Actual -0.15 -0.15 -0.17 -0.14
Revenue Estimate 270K 230K 260K 350K
Revenue Actual 112K 76K 0 189K

To track all earnings releases for PAVmed visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Recap: Kforce Q2 Earnings

Kforce (NASDAQ:KFRC) reported its Q2 earnings results on Monday, August 1, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Kforce missed estimated earnings by 1.69%, reporting an EPS of $1.16 versus an estimate of $1.18.

KFRC

Read More

This Cannabis Co. Expects Significant Growth Once Ohio’s Retail Market Launches, Reports Slight YoY Decrease In 2023 Revenue

Vext Science, Inc., which runs vertical cannabis operations in Arizona and Ohio, reported on Friday its financial results for the period ended Dec. 31, 2023. Revenue for 2023 slightly dropped year-over-year to $34.8 million from $35.4 million in 2022. Fourth quarter revenue grew year-year to $8.4 million, from $8.1 million in the prior year's quarter.

CSE:VEXT